Innovative reversible blood clotting agents for emergency treatment of internal bleeding
Currently, there is a lack of effective therapeutics for internal bleeding following a traumatic event. In this project, novel reversible blood clotting nanomaterials will be designed to be able to hunt for internal injuries and bleeding and then stop the bleeding quickly.
Every newly developed drug need to be tested through several rounds of animal testing before they can be tested on human. However, a rodent or chimp’s response to a medication does not alsway translate so smoothly in a person.
The research in Associate Professor Hang T. Ta’s Laboratory (CardiovasNanoMicro Lab) focuses on the development of advanced nanomaterials for molecular imaging, diagnosis, treatment and also theranostics of cardiovascular diseases, inflammatory diseases and bleeding disorders. The group is also dedicated to the development of cardiovascular disease on microfluidic devices for fundamental investigation of the disease, drug testing and screening, and also for diagnostics of the disease.